Panizzutti et al
Prolonged diarrhea depletes sodium, potassium, and other electrolytes that affect blood viscosity and cardiovascular function
This is a work in progress for every provider out there, as we are doing this experiment in real time - the use of GLP-1 for weight loss is at a scale way beyond how they have been used in the past for diabetes management
Elevated Energy: Some individuals detect a modest increase in daytime vitality and mental sharpness, enhancing everyday productivity
All doses of orforglipron in the ATTAIN-2 trial demonstrated a dose-dependent reduction in body weight and HbA1c at 72 weeks, Nasreen Alfaris , MD, MPH, consultant at the Obesity, Endocrine and Metabolism Center at King Fahad Medical City in Riyadh, Saudi Arabia, said during a presentation
Common Side Effects Most side effects are gastrointestinal and typically occur during the titration phase (the first 1620 weeks when your dose is slowly increasing): Very Common: Nausea (affects ~44% of users), diarrhea, vomiting, and constipation